Surgical therapy for esophageal carcinoma: a prospective 20-year analysis;Chirurgische therapie des ösophaguskarzinoms: eine prospektive 20-jahres-analyse

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 133, Issue 3, 2008, Pages 260-266

  Gockel, I ^a   Sultanov, F S ^a   Domeyer, M ^a   Trinh, T T ^a   Gonner U ^a   Junginger, T ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

20 year analysis; Adenocarcinoma; Long term developments; Squamous cell carcinoma; Surgical therapy of esophageal carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ANASTOMOSIS; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; DIAPHRAGM; DISEASE FREE SURVIVAL; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MALE; MASS COMMUNICATION; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STOMACH; THORACOTOMY;

ADENOCARCINOMA; ADULT; AGED; ANASTOMOSIS, SURGICAL; CARCINOMA, SQUAMOUS CELL; DIAPHRAGM; DIFFUSION OF INNOVATION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; STOMACH; THORACOTOMY;

EID: 47249102171     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1004738     Document Type: Article

References (33)

1. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-232
2. Bergman JJ, Tytgat GN. New developments in the endoscopic surveillance of Barrett's esophagus. Gut 2005; 54(Suppl 1): S38-S42
3. Bollschweiler E, Schroder W, Holscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the esophagus. BrJ Surg 2000; 87:1106-1110
4. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001 ; 92: 549-555
5. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654
6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JFJ. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289
7. Connor MJ, Sharma P. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia. Thorac Surg Clin 2004;14:87-94
8. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220
9. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83:2049-2053
10. Doty JR, Salazar JD, Forastiere AA, Heath EI, Kleinberg L, Heitmiller RF. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy, Ann Thorac Surg 2002; 74:227-231
11. Ellis Jr FH, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997; 113:836-846
12. Fiorica F, Di Bona D, Schepis F. Preoperative chemoradiotherapy for oesophageal cancer: A systemic review and meta-analysis. Gut 2004; 53:925-930
13. Gockel I, Exner C, Junginger T. Morbidity and mortality after esophagectomy for esophageal cancer: a risk analysis. World J Surg Oncol 2005; 3: 37
14. Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-term prognosis? World J Surg Oncol 2005 ; 3: 40
15. Gockel I, Kneist W. Junginger T. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J Surg 2006; 30:183-190
16. Goetz M, Hoffman A, Galle PR, Neurath MF, Kiesslich R. Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach. Future Oncol 2006; 2: 469-476
17. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevic V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus, N Engl J Med 1992; 11:1593-1598
18. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam Jr JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 2002; 236: 376-384
19. Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a metaanalysis. Ann Thorac Surg 2001 ; 72: 306-313
20. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, Ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662-1669
21. Junginger T, Dutkowski P. Selective approach to the treatment of esophageal cancer. BrJ Surg 1996; 83:1473-1477
22. Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. EurJ Surg Oncol 2006; 32: 749-755
23. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958 ; 53: 457 - 481
24. Kneist W, Schreckenberger M, Bartenstein P, Menzel C, Oberholzer K, Junginger T. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 2004; 139:1043-1049
25. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. AmJ Gastroenterol 2004; 99: 582-588
26. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002;95:2096-2102
27. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238: 339-347
28. Mashimo H, Wagh MS, Goyal RK. Surveillance and screening for Barrett esophagus and adenocarcinoma. J Clin Gastroenterol 2005; 39 (Suppl.2): S33-S41
29. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma. J Natl Cancer Inst 2005;97:142-146
30. Sampliner RE. Managing Barrett's esophagus: what is new in 2005? Dis Esophagus 2005; 18; 17-20
31. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical / topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361
32. SiewertJR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Tumor cell type is an independent prognostic parameter in esophageal cancer: lessons learned from more than 1000 consecutive resections at a single institution in the Western world. Ann Surg 2001 ; 234: 360-369
33. Urschel JD, Vasan HB. A meta-analysis of randomized controlled trials that compared neo-adjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543